Concepedia

Helena Aguilar

HA

14

Publications

743

Citations

11

H-Index

2004

Active since

Affiliations

Institut Català d'Oncologia(Current)

Institut d'Investigació Biomédica de Bellvitge

Institut d'Investigació Biomèdica de Girona

Centre for Biomedical Network Research on Rare Diseases

Bellvitge University Hospital

Helena Aguilar is an author at Institut Català d'Oncologia specializing in medicine, tumor biology, and cell biology.

Top concepts

Publications per year

2004–2024

14

Publications

14

Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer

Christopher A. Maxwell, Javier Benítez, Laia Gómez‐Baldó et al. · PLoS Biology · 2011 · 192 citations · Full text

Novel Inhibitors of Fatty Acid Synthase with Anticancer Activity

Teresa Puig, Carlos Turrado, Bellinda Benhamú et al. · Clinical Cancer Research · 2009 · 95 citations

, , +13

A novel inhibitor of fatty acid synthase shows activity against HER2+ breast cancer xenografts and is active in anti-HER2 drug-resistant cell lines

Teresa Puig, Helena Aguilar, Sílvia Cufí et al. · Breast Cancer Research · 2011 · 94 citations · Full text

IREM‐1 is a novel inhibitory receptor expressed by myeloid cells

Damiana Álvarez‐Errico, Helena Aguilar, Friederike Kitzig et al. · European Journal of Immunology · 2004 · 79 citations

, , +13

Human KIR2DL5 Is an Inhibitory Receptor Expressed on the Surface of NK and T Lymphocyte Subsets

E. Estefanía, Raquel Flores, Natalia Gómez‐Lozano et al. · The Journal of Immunology · 2007 · 65 citations

Rows per page

1–5 of 14